217 related articles for article (PubMed ID: 24105340)
41. New DNA methylation markers and global DNA hypomethylation are associated with oral cancer development.
Foy JP; Pickering CR; Papadimitrakopoulou VA; Jelinek J; Lin SH; William WN; Frederick MJ; Wang J; Lang W; Feng L; Zhang L; Kim ES; Fan YH; Hong WK; El-Naggar AK; Lee JJ; Myers JN; Issa JP; Lippman SM; Mao L; Saintigny P
Cancer Prev Res (Phila); 2015 Nov; 8(11):1027-35. PubMed ID: 26342026
[TBL] [Abstract][Full Text] [Related]
42. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
43. Association of shorter leucocyte telomere length with risk of frailty.
Bountziouka V; Nelson CP; Codd V; Wang Q; Musicha C; Allara E; Kaptoge S; Di Angelantonio E; Butterworth AS; Thompson JR; Curtis EM; Wood AM; Danesh JN; Harvey NC; Cooper C; Samani NJ
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1741-1751. PubMed ID: 35297226
[TBL] [Abstract][Full Text] [Related]
44. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
Lu M; Wang C; Chen W; Mao C; Wang J
DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
[TBL] [Abstract][Full Text] [Related]
45. ZEB1 as an indicator of tumor recurrence for areca quid chewing-associated oral squamous cell carcinomas.
Ho CM; Hu FW; Lee SS; Shieh TM; Yu CH; Lin SS; Yu CC
J Oral Pathol Med; 2015 Oct; 44(9):693-8. PubMed ID: 25367287
[TBL] [Abstract][Full Text] [Related]
46. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
[TBL] [Abstract][Full Text] [Related]
47. Estimation of serum lactate dehydrogenase level in patients with oral premalignant lesions/conditions and oral squamous cell carcinoma: a clinicopathological study.
Pereira T; Shetty S; Pereira S
J Cancer Res Ther; 2015; 11(1):78-82. PubMed ID: 25879341
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of Diagnostic Significance of Salivary miRNA-184 and miRNA-21 in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Garg A; Urs AB; Koner BC; Augustine J; Guru SA
Head Neck Pathol; 2023 Dec; 17(4):961-968. PubMed ID: 38015343
[TBL] [Abstract][Full Text] [Related]
49. Salivary Her2/neu Levels in Differentiation of Oral Premalignant Disorders and Oral Squamous Cell Carcinomas.
Varun C; Dineshkumar T; Jayant VS; Rameshkumar A; Rajkumar K; Rajashree P; Mathew J; Arunvignesh RK
Asian Pac J Cancer Prev; 2015; 16(14):5773-7. PubMed ID: 26320450
[TBL] [Abstract][Full Text] [Related]
50. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
51. Association of Epstein-Barr virus infection with oral squamous cell carcinoma in a case-control study.
Acharya S; Ekalaksananan T; Vatanasapt P; Loyha K; Phusingha P; Promthet S; Kongyingyoes B; Pientong C
J Oral Pathol Med; 2015 Apr; 44(4):252-7. PubMed ID: 25169715
[TBL] [Abstract][Full Text] [Related]
52. Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity.
Weaver AN; Burch MB; Cooper TS; Della Manna DL; Wei S; Ojesina AI; Rosenthal EL; Yang ES
Mol Cancer Res; 2016 Sep; 14(9):883-91. PubMed ID: 27353029
[TBL] [Abstract][Full Text] [Related]
53. The variant of pri-mir-26a-1 polymorphism is associated with decreased risk of betel quid-related oral premalignant lesions and oral squamous cell carcinoma.
Yang CM; Chen CC; Tseng YK; Huang SJ; Liou HH; Lee YC; Lee JH; Wang JS; Chen HC; Chi CC; Kang BH; Lin YC; Tsai KW; Ger LP
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Oct; 124(4):378-389.e1. PubMed ID: 28743663
[TBL] [Abstract][Full Text] [Related]
54. Smoking habits and leukocyte telomere length dynamics among older adults: Results from the ESTHER cohort.
Müezzinler A; Mons U; Dieffenbach AK; Butterbach K; Saum KU; Schick M; Stammer H; Boukamp P; Holleczek B; Stegmaier C; Brenner H
Exp Gerontol; 2015 Oct; 70():18-25. PubMed ID: 26255046
[TBL] [Abstract][Full Text] [Related]
55. Recurrent chromosomal and epigenetic alterations in oral squamous cell carcinoma and its putative premalignant condition oral lichen planus.
Németh CG; Röcken C; Siebert R; Wiltfang J; Ammerpohl O; Gassling V
PLoS One; 2019; 14(4):e0215055. PubMed ID: 30964915
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of premalignant potential in oral lichen planus using interphase cytogenetics.
Kim J; Yook JI; Lee EH; Ryu MH; Yoon JH; Hong JC; Kim DJ; Kim HS
J Oral Pathol Med; 2001 Feb; 30(2):65-72. PubMed ID: 11168849
[TBL] [Abstract][Full Text] [Related]
57. Metabolic landscape of oral squamous cell carcinoma.
Vitório JG; Duarte-Andrade FF; Dos Santos Fontes Pereira T; Fonseca FP; Amorim LSD; Martins-Chaves RR; Gomes CC; Canuto GAB; Gomez RS
Metabolomics; 2020 Sep; 16(10):105. PubMed ID: 33000429
[TBL] [Abstract][Full Text] [Related]
58. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
59. Pretreatment peripheral blood leukocytes are independent predictors of survival in oral cavity cancer.
Valero C; Zanoni DK; McGill MR; Ganly I; Morris LGT; Quer M; Shah JP; Wong RJ; León X; Patel SG
Cancer; 2020 Mar; 126(5):994-1003. PubMed ID: 31809562
[TBL] [Abstract][Full Text] [Related]
60. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage.
Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M
Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
